News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
11,395 Results
Type
Article (108)
Company Profile (2)
Press Release (11285)
Section
Business (5892)
Career Advice (5)
Deals (810)
Drug Delivery (1)
Drug Development (783)
FDA (211)
Job Trends (214)
News (7479)
Policy (435)
Tag
Academia (25)
Alliances (450)
ALS (2)
Alzheimer's disease (18)
Antibody-drug conjugate (ADC) (9)
Approvals (214)
Artificial intelligence (3)
Bankruptcy (8)
Best Places to Work (203)
Biosimilars (1)
Biotechnology (4)
Breast cancer (16)
Cancer (44)
Cardiovascular disease (4)
Career advice (5)
CAR-T (3)
CDC (1)
Cell therapy (4)
Clinical research (721)
Collaboration (8)
Compensation (3)
COVID-19 (22)
C-suite (2)
Data (70)
Depression (2)
Diabetes (2)
Diagnostics (84)
Digital health (1)
Drug discovery (1)
Drug pricing (1)
Earnings (5769)
Events (875)
Executive appointments (2)
FDA (293)
Funding (13)
Gene editing (1)
Gene therapy (2)
GLP-1 (10)
Government (28)
Guidances (59)
Healthcare (361)
HIV (3)
IgA nephropathy (3)
Immunology and inflammation (6)
Immuno-oncology (1)
Indications (1)
Infectious disease (23)
Inflammatory bowel disease (3)
Influenza (1)
IPO (597)
IRA (1)
Job creations (24)
Job search strategy (5)
JPM (1)
Legal (105)
Liver cancer (1)
Lung cancer (3)
Lymphoma (4)
Manufacturing (3)
MASH (3)
Medical device (273)
Medtech (276)
Mergers & acquisitions (217)
Metabolic disorders (7)
mRNA (1)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (5)
Neuroscience (28)
NextGen: Class of 2026 (56)
Non-profit (23)
Obesity (1)
Ovarian cancer (3)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (2)
Partnered (1)
Patents (1)
Patient recruitment (1)
People (329)
Pharmacy benefit managers (1)
Phase 1 (183)
Phase 2 (276)
Phase 3 (301)
Pipeline (304)
Policy (1)
Postmarket research (26)
Preclinical (61)
Prostate cancer (2)
Radiopharmaceuticals (4)
Rare diseases (4)
Real estate (35)
Regulatory (332)
Reports (1)
Research institute (17)
RSV (1)
Schizophrenia (2)
Series A (1)
Series B (1)
Sponsored (1)
Startups (16)
Vaccines (4)
Weight loss (1)
Women's health (3)
Date
Last 7 days (9)
Last 30 days (51)
Last 365 days (544)
2026 (138)
2025 (560)
2024 (765)
2023 (876)
2022 (987)
2021 (1056)
2020 (1093)
2019 (747)
2018 (565)
2017 (426)
2016 (236)
2015 (330)
2014 (256)
2013 (250)
2012 (334)
2011 (318)
2010 (440)
Location
Africa (4)
Alabama (3)
Arizona (4)
Asia (432)
Australia (38)
California (213)
Canada (159)
China (16)
Colorado (12)
Connecticut (9)
Delaware (2)
Europe (1189)
Florida (64)
Georgia (11)
Idaho (1)
Illinois (14)
India (3)
Indiana (16)
Japan (8)
Kansas (2)
Kentucky (3)
Louisiana (7)
Maine (3)
Maryland (15)
Massachusetts (122)
Michigan (5)
Minnesota (25)
Missouri (3)
Nevada (5)
New Jersey (76)
New York (54)
North Carolina (21)
Northern California (119)
Ohio (5)
Pennsylvania (55)
South America (8)
South Carolina (2)
Southern California (84)
Tennessee (5)
Texas (27)
United States (799)
Utah (8)
Virginia (1)
Washington D.C. (1)
Washington State (14)
Wisconsin (3)
11,395 Results for "514".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at ECO 2026
March 20, 2026
·
5 min read
Press Releases
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association’s 2026 Scientific Sessions
April 2, 2026
·
5 min read
Press Releases
Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
December 25, 2025
·
6 min read
Press Releases
Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025
June 10, 2025
·
4 min read
Press Releases
Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
May 14, 2025
·
3 min read
Press Releases
Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat
July 28, 2025
·
4 min read
Policy
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum’s Disease
Caliway Biopharmaceuticals announced that the U.S. Food and Drug Administration granted Orphan Drug Designation to CBL-514 for Dercum’s disease treatment.
March 3, 2024
·
4 min read
Press Releases
Caliway’s CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal
March 12, 2025
·
6 min read
Caliway Received U.S. FDA Fast Track Designation for CBL-514 for the Treatment of Dercum’s Disease
Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of CBL-514 in Dercum’s disease treatment.
February 14, 2024
·
5 min read
Press Releases
Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum’s Disease at World Orphan Drug Congress USA 2025
April 18, 2025
·
5 min read
1 of 1,140
Next
